ANTI-TL1A (TNFSF15) ANTIBODY FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE Application EP-4105236-A1 European Patent Office 21 Dec 2022
Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3… Grant US-10633449-B2 United States of America 28 Apr 2020
TREATING FIBROSIS BY INHIBITING TL1A AND DIAGNOSING FIBROSIS BY DETECTING IL31RA Grant EP-2978440-B1 European Patent Office 02 Oct 2019
SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY Application EP-3022295-A4 European Patent Office 01 Mar 2017
TREATING FIBROSIS AND INFLAMMATION BY INHIBITING TL1A Application EP-2978440-A4 European Patent Office 18 Jan 2017